Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase Inhibitors FAQ
PDF | English
Image For Activity Cover
Availability
On-Demand
Cost
$0.00
Credit Offered
No Credit Offered
A quick FAQ document about the CAP/IASLC/AMP guideline that provides vital information at a glance.
Powered By